Citations

At AxisPharm, we are dedicated to supporting a diverse array of global clients in their advanced research and development activities. Our expertise encompasses new drug discovery, drug delivery, diagnostics, and a variety of biomedical fields. We are committed to providing innovative, high-quality products and exceptional service. Our efforts have been recognized in numerous publications that cite the utilization of AxisPharm’s products and our analytical and bioanalytical services across a broad spectrum of research disciplines.

  1. Yin, F., Ahsan, F., Pinkas, J., Das, B., Wang, F., Zheng, N., Hahn, D., Amrite, A., Feng, J., Adhikari, D. and Sikora, J., 2023. A sensitive LC–MS/MS assay to quantitate free payload Aur0101 from ADC PYX-201 in rat and monkey plasma. Bioanalysis, 15(14), pp.833-843.
  2. Yin, F., Adhikari, D., Peay, M., Cortes, D., Garada, M., Woolf, M.S., Ma, E., Lebarbenchon, D., Mylott, W., Dyszel, M. and Harriman, S., 2023. Development and validation of a hybrid immunoaffinity LC–MS/MS assay for quantitation of total antibody (TAb) from an antibody drug conjugate (ADC) PYX-201 in human plasma. Journal of Chromatography B, 1228, p.123844.
  3. Bruno, J.G. and John, J., 2020. Preliminary development of a competitive fluorescent quantum dot-based immunochromatographic test strip for sensitive saxitoxin detection. Sensor Letters, 18(6), pp.459-463.
  4. Yin, F., DeCiantis, C., Pinkas, J., Das, B., Wang, F., Zheng, N., Hahn, D., Amrite, A., Feng, J., Adhikari, D. and Kane, C., 2023. Quantitation of total antibody (tAb) from antibody drug conjugate (ADC) PYX-201 in rat and monkey plasma using an enzyme-linked immunosorbent assay (ELISA) and its application in preclinical studies. Journal of Pharmaceutical and Biomedical Analysis, 233, p.115452.
  5. Sarli, S.L., 2024. Advancing Oligonucleotide Technologies for Malignant Brain Tumors and Other Central Nervous System Diseases (Doctoral dissertation, UMass Chan Medical School).
  6. Kiss, B. and Borbély, J., 2023. Business risk mitigation in the development process of new monoclonal antibody drug conjugates for cancer treatment. Pharmaceutics, 15(6), p.1761.
  7. Sarli, S.L., Fakih, H.H., Kelly, K., Devi, G., Rembetsy-Brown, J.M., McEachern, H.R., Ferguson, C.M., Echeverria, D., Lee, J., Sousa, J. and Sleiman, H.F., 2024. Quantifying the activity profile of ASO and siRNA conjugates in glioblastoma xenograft tumors in vivo. Nucleic Acids Research, 52(9), pp.4799-4817.
  8. Connor, C., Connor, M., Yue, D., Chang, C.L., Eickhoff, J. and Wagner, S., 2020. Changes in Tripeptides Produced by the LifeWave X-39 patch. International Journal of Healing and Caring Online.
  9. Kang, J., 2024. Application of Green Toxicology in Personal Care Products. Journal of Student Research, 13(2).
  10. Thoreau, F., Rochet, L.N., Baker, J.R. and Chudasamaa, V., ESI: Enabling the formation of native mAb, Fab’and Fc-conjugates using a bis-disulfide bridging reagent to achieve tunable payload-to-antibody ratios (PARs).
  11. Connor, C., Connor, M., Yue, D., Eickhoff, J. and Wagner, S., 2021. Double-Blind Testing of the Lifewave X39 Patch to Determine GHK-Cu Production Levels. Internal Med Res Open J, 6(1), pp.1-3.
  12. Hinton, S.R., Corpuz, E.L., Holman, K.L.M. and Meyer, S.C., 2022. A split β-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs. Journal of Inorganic Biochemistry, 236, p.111986.
  13. Sulthana, S., Bhatti, A., Mathew, E., Quazi, S.H., Gaudreault, N.N., DeLong, R. and Aryal, S., 2024. Synthetic graphene–copper nanocomposites interact with the hACE-2 enzyme and inhibit its biochemical activity. Nanoscale Advances, 6(1), pp.188-196.
  14. Eickhoff, J., Perry, M. and Young, D., LifeWave X49TM patch supports improved results in Fitness, Strength and Stamina.
  15. Wright, C., 2023. Antibody-drug-conjugates: The recent developments and Trastuzumab deruxtecan in the treatment of HER2 breast cancer.
  16. Wang, L., 2019. Total Synthesis of Marine Natural Products: Micromide, Its Analogs, and Lagunamide A. University of California, San Diego.
  17. Sockett, K.A., Loffredo, M., Korunes-Miller, J., Varghese, M. and Grinstaff, M.W., 2022. Synthesis and characterization of carbohydrate-based biosurfactant mimetics. Carbohydrate research, 522, p.108697.
  18. Liu, X., Chen, Q., Ji, X., Yu, W., Wang, T., Han, J., Li, S., Liu, J., Zeng, F., Zhao, Y. and Zhang, Y., 2022. Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor. Frontiers in Pharmacology, 13, p.939483.
  19. Murbach, T.S., Glávits, R., Moghadam Maragheh, N., Endres, J.R., Hirka, G., Goodman, R.E., Lu, G., Vértesi, A., Béres, E. and Pasics Szakonyiné, I., 2022. Evaluation of the genotoxic potential of protoporphyrin IX and the safety of a protoporphyrin IX‐rich algal biomass. Journal of Applied Toxicology, 42(7), pp.1253-1275.
  20. Sheehy, T.L., Kwiatkowski, A.J., Arora, K., Kimmel, B.R., Schulman, J.A., Gibson-Corley, K.N. and Wilson, J.T., 2024. STING-Activating Polymer–Drug Conjugates for Cancer Immunotherapy. ACS Central Science.
  21. Singh, S.S., Calvo, R., Kumari, A., Sable, R.V., Fang, Y., Tao, D., Hu, X., Castle, S.G., Nahar, S., Li, D. and Major, E., 2024. Fatty acid derivatization and cyclization of the immunomodulatory peptide RP-182 targeting CD206high macrophages improves anti-tumor activity. Molecular Cancer Therapeutics.
  22. Yin, F., Adhikari, D., Li, Y., Turner, D., Woolf, M.S., Lebarbenchon, D., Ma, E., Mylott, W., Shaheen, E., Harriman, S. and Pinkas, J., 2023. A sensitive and rapid LC-MS/MS assay for quantitation of free payload Aur0101 from antibody drug conjugate (ADC) PYX-201 in human plasma. Journal of Chromatography B, 1226, p.123786.
  23. Yin, F., Adhikari, D., Sun, M., Woolf, M.S., Ma, E., Mylott, W., Shaheen, E., Harriman, S. and Pinkas, J., 2023. Bioanalysis of an antibody drug conjugate (ADC) PYX-201 in human plasma using a hybrid immunoaffinity LC–MS/MS approach. Journal of Chromatography B, 1223, p.123715.
  24. Cashman, J.R., Ryan, D., McKeithan, W.L., Okolotowicz, K., Gomez-Galeno, J., Johnson, M., Sampson, K.J., Kass, R.S., Pezhouman, A., Karagueuzian, H.S. and Mercola, M., 2021. Antiarrhythmic hit to lead refinement in a dish using patient-derived iPSC cardiomyocytes. Journal of Medicinal Chemistry, 64(9), pp.5384-5403.
  25. Cho, H., Jeon, S.I., Shim, M.K., Ahn, C.H. and Kim, K., 2023. In situ albumin-binding and esterase-specifically cleaved BRD4-degrading PROTAC for targeted cancer therapy. Biomaterials, 295, p.122038.
  26. Orne, C.E., 2023. Vaccinogenic and Therapeutic Applications of Burkholderia Polysaccharides. University of Nevada, Reno.
  27. Kilgour, K.M., 2023. Affinity Binding of Proteins and Peptides for Rapid Antibody Quantification and Growth Factor Display (Doctoral dissertation, North Carolina State University).
  28. Min, Y., Chen, Y., Wang, L., Ke, Y., Rong, F., He, Q., Paerhati, P., Zong, H., Zhu, J., Wang, Y. and Zhang, B., 2024. Supramolecular antibody-drug conjugates for combined antibody therapy and photothermal therapy targeting HER2-positive cancers. International Journal of Biological Macromolecules, 278, p.134622.
  29. Chis, A.A., Dobrea, C.M., Arseniu, A.M., Frum, A., Rus, L.L., Cormos, G., Georgescu, C., Morgovan, C., Butuca, A., Gligor, F.G. and Vonica-Tincu, A.L., 2024. Antibody–Drug Conjugates—Evolution and Perspectives. International Journal of Molecular Sciences, 25(13), p.6969.
  30. Keita, K., 2021. Elucidation of the Active Components of Medicinal Plant Extracts and Their Effects on Antibiotic-Resistant Bacteria (Doctoral dissertation, Alabama Agricultural and Mechanical University).
  31. 조한희, 2023. Lysosomal enzyme specific nanodrugs for targeted cancer therapy (Doctoral dissertation, 서울대학교 대학원).
  32. Clark, A.D., 2023. Exploiting Virus-Like Particle Self-Assembly to Encapsulate Gold Nanoparticles Inside of a Capsid (Master’s thesis, California State University, Fresno).
  33. Segawa, S., Wu, J., Kwok, R.T., Wong, T.T., He, X. and Tang, B.Z., 2024. Co‐aggregation as A Simple Strategy for Preparing Fluorogenic Tetrazine Probes with On‐Demand Fluorogen Selection. Angewandte Chemie International Edition, 63(11), p.e202313930.
  34. Maujean, T., Ramanoudjame, S.M., Riché, S., Le Guen, C., Boisson, F., Muller, S., Bonnet, D., Gulea, M. and Marchand, P., 2024. Hetero-Diels–Alder and CuAAC Click Reactions for Fluorine-18 Labeling of Peptides: Automation and Comparative Study of the Two Methods. Molecules, 29(13), p.3198.
  35. Malsagova, K.A., Kopylov, A.T., Stepanov, A.A., Kulikova, L.I., Izotov, A.A., Yurku, K.A., Balakin, E.I., Pustovoyt, V.I. and Kaysheva, A.L., 2024. Metabolomic and Proteomic Profiling of Athletes Performing Physical Activity under Hypoxic Conditions. Sports, 12(3), p.72.
  36. Zhu, Y., 2022. Microfluidic Generation of Viscoelastic Artificial Antigen Presenting Cells for T Cell Activation. University of California, Los Angeles.
  37. Zhang, T., 2023. Visible Light-Mediated Polymerization for Protein-Polymer Conjugation: A Biocompatible Tool for Therapeutic Applications (Doctoral dissertation, UNSW Sydney).
  38. Mh, C. and Ca, C., 2022. Bone and Muscle Support in Ageing Women with Life Wave X49 TM Patch. Biomedical Journal of Scientific & Technical Research, 47(3), pp.38581-38590.
  39. Nurhidayanti, N., 2023. ERBANDINGAN NILAI C-REACTIVE PROTEIN METODE aglutinasi Lateks DAN METODE FLUORESCENCE IMMUNOASSAY (FIA) PADA PASIEN PRA SECTIO. Masker Medika, 11(2), pp.354-360.
  40. BAČOVÁ, P.T., NEPŘÍMÁ ANALÝZA RAKOVINNÝCH MARKERŮ POMOCÍ TAG-LIBS S VYUŽITÍM MAGNETICKÝCH MIKROČÁSTIC.
  41. STING-Activating Polymer–Drug Conjugates for Cancer Immunotherapy, ACS Cent. Sci. 2024, 10, 9, 1765–1781.